close
MENU
Investment
3 mins to read

Why private sector vital for clinical trial business


Melody Brandon
Wed, 11 Apr 2012

Private industry involvement in the health and innovation hub is vital to securing overseas investors for New Zealand’s health technology sector.

National's Dr Paul Hutchison, chairman of the health select committee, told NBR Online it should not just be left to the Health

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Melody Brandon
Wed, 11 Apr 2012
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Why private sector vital for clinical trial business
Investment,
19956
true